Address And Details

875 Third Avenue , New York, NY 10022
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The fund seeks total return in excess of inflation through capital growth and current income. The fund will invest at least 80% of its net assets, plus the amount of any borrowings for investment purposes (calculated at the time of any investment), in a combination of investments that the Advisor believes offer exposure to real assets. Currently, the Advisor intends to seek exposure to the following real assets categories (either directly or through investments in companies that own or derive a significant portion of their value from such real assets or the production thereof): real estate (REITs and real estate operating companies), commodities (commodity futures), natural resource related equities (energy, metals and mining, paper and forestry, chemicals), infrastructure (regulated utilities, transport, communications, pipelines, seaports, airports and toll roads), gold and other precious metals, master limited partnerships (MLPs), Treasury Inflation-Protected Securities (TIPS) and other fixed income securities.

Net Asset Value

as of 5:35 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.64%
  • 1 Month
  • -0.56%
  • 3 Months
  • -0.40%
  • 1 Yr Return
  • +22.48%
  • 5 Yr Return
  • +43.84%

Equity Sector Breakdown

Finance 16.58%
IndustrialCyclical 16.49%
Utilities 11.86%
NonDurables 7.01%
Energy 5.60%
Services 4.84%
Technology 3.52%
ConsumerDurables n/a
Health n/a
RetailTrade n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 81.50%
ForeignStocks 37.36%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 305.44 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -1.10 -2.32 -3.56
Beta 0.66 0.63 0.55
R Squared 0.80 0.71 0.64
Std Deviation 13.67 11.26 9.29
Sharpe Ratio 0.79 0.76 n/a

Purchase Information

as of 5:23 PM ET 09/16/2021
Minimum Initial $2500
Minimum Additional $50
Minimum Initial IRA $1000

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +27.33%
  • +32.39%
+27.33% +32.39%
3 Year
  • +11.29%
  • +10.68%
+11.29% +10.68%
10 Year
  • +5.36%
  • +4.88%
+5.36% +4.88%
Life Of Fund
  • +4.33%
  • +4.21%
+4.33% +4.21%

Top 10 Holdings

Symbol Company Name % Of Assets
CCI CROWN CASTLE INTL CORP 3.77%
LNG CHENIERE ENERGY INC 2.93%
AMT AMERICAN TOWER CORP 2.04%
TRP TC ENERGY CORPORATION 1.77%
SRE SEMPRA ENERGY 1.60%
WMB WILLIAMS COMPANIES INC 1.58%
WCN WASTE CONNECTIONS INC NEW 1.53%
SBAC SBA COMMUNICATIONS CORP 1.43%
FCX FREEPORT MCMORAN INC 1.39%
PPL PEMBINA PIPELINE CORPORATION 1.35%

Recent Articles from TheStreet

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

5 Top Stock Gainers for Monday: AstraZeneca, Astronics, Teradata

AstraZeneca, Brooks Automation, Teradata, Atea Pharmaceuticals and Astronics are five top stock gainers for Monday.

Adobe Lead

Adobe Initiates at Overweight by Wells Fargo

Adobe is 'one of the crown jewels of software,' a Wells Fargo analyst says.

Bitcoin Down Lead

Bitcoin Gets Blasted, But Should You Buy the Dip or Wait?

Bitcoin prices are getting smashed on Monday. So far support is holding, but is it dependable enough to buy? Let's look at the chart.

Nasdaq-listed Chinese Electric Carmaker Li Auto Apologises For Passing Off Recall Of 10,469 Li ONEs As 'upgrade' Offer

Chinese EV Maker Li Cuts Delivery Forecast, Shares Fall

Li trims its forecast to 24,500 vehicle deliveries for the third quarter from 25,000 to 26,000.

Toys 'R' Us Sells FAO Schwarz as it Reveals Further Debt Refinancing Plans

Toymakers Facing Holiday Challenge Due to Supply-Chain Issues

Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Twitter Blue Lead

Twitter to Pay $810M to Settle Holder Suit Over User Engagement

Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.

Starboard Takes Stake in CVS Health Corp.: Report

CVS to Add 25,000 Workers Ahead of Flu Season, Covid Booster Shots

Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.